+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Radiopharmaceuticals Market by Radioisotope Type, Delivery Format, Production Technology, Application, End User - Global Forecast to 2030- Product Image
Radiopharmaceuticals Market by Radioisotope Type, Delivery Format, Production Technology, Application, End User - Global Forecast to 2030- Product Image
Sale

Radiopharmaceuticals Market by Radioisotope Type, Delivery Format, Production Technology, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829949
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Radiopharmaceuticals Market grew from USD 5.48 billion in 2024 to USD 5.84 billion in 2025. It is expected to continue growing at a CAGR of 6.51%, reaching USD 8.00 billion by 2030.

Empowering Precision Medicine with Radiopharmaceutical Innovation

Radiopharmaceuticals occupy a pivotal niche at the intersection of diagnosis and therapy, harnessing the power of radioisotopes to drive precision medicine forward. As cancer incidence rises globally and chronic diseases demand more precise diagnostic tools, the industry1s innovations in molecular imaging and targeted radiotherapy have never been more consequential. This report delves into the multifaceted landscape of radiopharmaceuticals, illuminating the scientific breakthroughs, regulatory shifts, and market trends shaping the next decade.

This introduction outlines the critical drivers of growth, from enhanced isotope purity and synthesis technologies to expanding clinical applications across oncology, cardiology, neurology, and endocrinology. It also frames the context for understanding how evolving reimbursement policies and public health imperatives are setting the stage for an unprecedented expansion of nuclear medicine capabilities. By establishing this foundation, readers gain clear insight into why radiopharmaceuticals are poised to redefine standards of patient care and present transformative commercial opportunities.

Navigating the New Frontiers of Radiopharmaceutical Development

The radiopharmaceutical sector is undergoing a profound transformation driven by the convergence of advanced molecular imaging, theranostic approaches, and digital health integrations. Novel radioisotopes are being combined with precision-targeting vectors, enabling simultaneous diagnosis and therapy that accelerates treatment planning and improves patient outcomes. Strategic regulatory approvals have catalyzed this shift, with health authorities increasingly recognizing the value of personalized nuclear medicine treatments.

Supply chain innovations further reinforce this evolution. Decentralized production models, including compact cyclotrons and on-site generator systems, are becoming integral to ensuring timely access to short-lived isotopes. At the same time, artificial intelligence is enhancing image analysis, dose optimization, and patient monitoring. Together, these forces are redefining clinical pathways, reducing time to diagnosis, and expanding the range of treatable conditions in ways previously unimaginable.

Unpacking the US Tariff Impact on Radiopharmaceutical Supply Chains

The implementation of revised United States tariffs in 2025 has induced measurable shifts across the radiopharmaceutical supply chain, heightening costs for key imported reagents, equipment, and isotopes. Early-stage synthesis modules and specialized consumables have seen price increases that reverberate through production budgets, compelling manufacturers to reassess vendor relationships and cost structures. In response, some industry players are relocating critical manufacturing steps domestically, investing in local cyclotron capacity and generator-based production to mitigate tariff burdens.

Despite these challenges, the tariff adjustments have incentivized innovation in supply chain resilience. Collaborative procurement agreements and strategic stockpiling of essential materials are emerging as interim solutions. Over time, a more robust domestic infrastructure is anticipated to deliver greater pricing stability, reduced lead times, and enhanced control over quality standards. Ultimately, while the short-term impacts include cost volatility, the long-term outcome may be a more self-reliant and agile market ecosystem.

Strategic Segment Analysis Illuminating Radiopharmaceutical Market Dynamics

A nuanced analysis of the market reveals that radioisotope type dictates much of the competitive landscape. Fluorine-18 remains the cornerstone of diagnostic imaging, with FDG serving as the workhorse for oncology scans while NaF and PSMA tracers gain traction in bone and prostate cancer applications, respectively. Gallium-68, propelled by DOTA peptide targeting agents and emerging PSMA ligands, is rapidly expanding the scope of neuroendocrine tumor assessment. Iodine-131 maintains dual utility in diagnostic and therapeutic contexts, whereas Lutetium-177 has surged as a preferred radioligand therapy for a range of malignancies. Technetium-99m continues to underpin conventional imaging across cardiology and neurology.

When examining delivery formats, the market is bifurcated between kits that offer on-site preparation flexibility and ready-to-use formulations that prioritize operational efficiency and regulatory compliance. This dichotomy influences purchasing decisions, with large hospital networks favoring bulk kit procurement and smaller diagnostic centers opting for pre-prepared doses. Production technology further stratifies industry players: automated synthesis modules enhance consistency and throughput, cyclotron-based systems cater to high-volume facilities, generator-based processes provide portability and rapid deployment, and reactor-based production underpins large-scale isotope supply.

Diverse applications shape demand patterns, with oncology leading adoption due to the precision of molecular targeting. Cardiology and neurology follow, leveraging radiotracers for early detection of cardiovascular disease and neurodegenerative disorders. In endocrinology, innovations in thyroid imaging and therapy sustain Iodine-131 usage. The end-user landscape spans clinics seeking compact solutions, large diagnostic centers demanding high throughput, hospitals integrating imaging with comprehensive care pathways, and research institutes driving next-generation tracer development.

Collectively, these segmentation insights underscore the importance of aligning product offerings with specific customer needs, harnessing technological advancements, and anticipating shifts in clinical demand to capture higher market share.

Geographic Insights Driving Radiopharmaceutical Market Expansion

A regional lens reveals that the Americas lead in radiopharmaceutical adoption, driven by robust reimbursement frameworks, a dense network of nuclear medicine facilities, and continuous investment in clinical research. The presence of major pharmaceutical manufacturers and a favorable regulatory environment accelerate the introduction of new radiotracers. In contrast, Europe, the Middle East, and Africa exhibit mixed maturity levels: Western European markets show steady growth anchored by comprehensive healthcare systems and collaborative cross-border research initiatives, while emerging EMEA regions are investing to build foundational infrastructure and cultivate local production capabilities.

In the Asia-Pacific region, rapid economic development, expanding healthcare coverage, and government incentives are spurring interest in radiopharmaceutical applications. Countries with established cyclotron facilities are enhancing capacity to meet domestic demand, while others are forging international partnerships to bridge technical gaps. These dynamics create a competitive landscape characterized by varying adoption timelines, distinct regulatory pathways, and diverse investment priorities. Recognizing these differences enables stakeholders to tailor market entry and expansion strategies effectively.

Competitive Landscape and Leading Innovators in Radiopharmaceuticals

The competitive fabric of the radiopharmaceutical market is woven by a mix of established conglomerates and agile specialized firms. Leading players boast integrated portfolios spanning isotope production, tracer development, and supply chain services, leveraging global footprints to ensure reliability and quality. Recent years have seen strategic mergers to consolidate manufacturing capabilities, as well as alliances aimed at co-developing novel theranostic agents.

Simultaneously, small and mid-sized innovators are carving out niches by focusing on high-value tracers, novel chelation chemistries, and optimized delivery platforms. Their partnerships with academic centers accelerate early-stage research, while collaborations with contract manufacturing organizations facilitate scalability. This dynamic interplay between scale and specialization fosters a competitive environment that rewards both breadth of capabilities and depth of expertise. Companies that balance global reach with rapid innovation cycles are best positioned to spearhead next-generation radiopharmaceutical breakthroughs.

Actionable Strategies to Thrive in the Radiopharmaceutical Market

To capitalize on the expanding opportunity, industry leaders should prioritize investments in decentralized production infrastructures, enabling rapid on-site isotope availability and minimizing logistical constraints. Aligning R&D portfolios with emerging theranostic paradigms will unlock new clinical applications and enhance patient outcomes. Establishing strategic collaborations with academic and clinical centers can accelerate validation of novel tracers, while co-development agreements with technology providers will support seamless digital integration for imaging and data analytics.

Efficient supply chain management, including diversified sourcing and predictive inventory models, will mitigate risks associated with regulatory changes and tariff fluctuations. Companies should also engage proactively with policymakers to shape favorable reimbursement frameworks that reflect the clinical value of radiopharmaceuticals. Finally, a patient-centric approach to commercialization-incorporating educational initiatives for healthcare providers and care teams-will drive acceptance and utilization, solidifying market leadership in this rapidly evolving field.

Comprehensive Methodological Framework for Market Analysis

This report1s insights are grounded in a rigorous research methodology combining primary and secondary sources. An extensive series of in-depth interviews with C-level executives, clinical experts, and regulatory authorities provided firsthand perspectives on innovation trends and market challenges. These qualitative inputs were complemented by analysis of company reports, press releases, patent databases, and regulatory filings to ensure comprehensive coverage of competitive activities.

Quantitative data were triangulated across multiple proprietary and public databases to enhance accuracy, with segmentation frameworks validated through cross-referenced industry metrics. Regional market dynamics were examined using healthcare expenditure statistics and nuclear medicine facility registries. Throughout the process, methodological checks were implemented to maintain consistency, and findings were peer-reviewed by subject-matter experts to guarantee reliability and relevance.

Synthesizing Insights to Chart the Future of Radiopharmaceuticals

The synthesis of these insights paints a compelling picture of an industry on the cusp of transformative growth. Radiopharmaceuticals are advancing from niche diagnostic tools to cornerstone components of precision medicine, with expanding clinical indications and deeper integration into standard care pathways. Despite short-term disruptions from tariff adjustments and supply chain realignments, long-term prospects remain robust, driven by technological innovations and growing demand for personalized therapies.

As stakeholders navigate shifting regulatory, competitive, and regional dynamics, the ability to anticipate changes, invest in strategic capabilities, and forge collaborative partnerships will determine who leads the next wave of radiopharmaceutical breakthroughs. This conclusion underscores the critical need for data-driven decision-making and proactive strategy formulation in an environment defined by rapid scientific progress and evolving patient needs.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Radioisotope Type
    • Fluorine-18
      • FDG
      • NaF
      • PSMA
    • Gallium-68
      • DOTA Peptides
      • PSMA
    • Iodine-131
      • Diagnostic
      • Therapeutic
    • Lutetium-177
    • Technetium-99m
  • Delivery Format
    • Kits
    • Ready To Use
  • Production Technology
    • Automated Synthesis Modules
    • Cyclotron Based
    • Generator Based
    • Reactor Based
  • Application
    • Cardiology
    • Endocrinology
    • Neurology
    • Oncology
  • End User
    • Clinics
    • Diagnostic Centres
    • Hospitals
    • Research Institutes
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Curium NV
  • Lantheus Holdings, Inc.
  • Cardinal Health, Inc.
  • Eckert & Ziegler AG
  • Jubilant Pharmova Limited
  • GE HealthCare Technologies Inc.
  • Bayer AG
  • Novartis AG
  • Nordion Inc.
  • Ion Beam Applications SA

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Radiopharmaceuticals Market, by Radioisotope Type
8.1. Introduction
8.2. Fluorine-18
8.2.1. FDG
8.2.2. NaF
8.2.3. PSMA
8.3. Gallium-68
8.3.1. DOTA Peptides
8.3.2. PSMA
8.4. Iodine-131
8.4.1. Diagnostic
8.4.2. Therapeutic
8.5. Lutetium-177
8.6. Technetium-99m
9. Radiopharmaceuticals Market, by Delivery Format
9.1. Introduction
9.2. Kits
9.3. Ready to Use
10. Radiopharmaceuticals Market, by Production Technology
10.1. Introduction
10.2. Automated Synthesis Modules
10.3. Cyclotron Based
10.4. Generator Based
10.5. Reactor Based
11. Radiopharmaceuticals Market, by Application
11.1. Introduction
11.2. Cardiology
11.3. Endocrinology
11.4. Neurology
11.5. Oncology
12. Radiopharmaceuticals Market, by End User
12.1. Introduction
12.2. Clinics
12.3. Diagnostic Centres
12.4. Hospitals
12.5. Research Institutes
13. Americas Radiopharmaceuticals Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Radiopharmaceuticals Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Radiopharmaceuticals Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Curium NV
16.3.2. Lantheus Holdings, Inc.
16.3.3. Cardinal Health, Inc.
16.3.4. Eckert & Ziegler AG
16.3.5. Jubilant Pharmova Limited
16.3.6. GE HealthCare Technologies Inc.
16.3.7. Bayer AG
16.3.8. Novartis AG
16.3.9. Nordion Inc.
16.3.10. Ion Beam Applications SA
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. RADIOPHARMACEUTICALS MARKET MULTI-CURRENCY
FIGURE 2. RADIOPHARMACEUTICALS MARKET MULTI-LANGUAGE
FIGURE 3. RADIOPHARMACEUTICALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2024 VS 2030 (%)
FIGURE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. RADIOPHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. RADIOPHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. RADIOPHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY FDG, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NAF, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PSMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DOTA PEPTIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PSMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY LUTETIUM-177, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY TECHNETIUM-99M, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY READY TO USE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY AUTOMATED SYNTHESIS MODULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CYCLOTRON BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY GENERATOR BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY REACTOR BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY DIAGNOSTIC CENTRES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL RADIOPHARMACEUTICALS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES RADIOPHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 59. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 60. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 61. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 62. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 63. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. CANADA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 67. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 68. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 69. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 70. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 71. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. MEXICO RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 107. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 108. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 109. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 110. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 111. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 112. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. GERMANY RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 116. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 117. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 118. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 119. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 120. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. FRANCE RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 131. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 132. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 133. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 134. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 135. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 136. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. ITALY RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 140. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 141. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 142. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 143. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 144. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. SPAIN RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 171. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 172. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 173. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 174. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 175. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 176. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 178. DENMARK RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 187. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 189. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 190. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 191. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 192. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 193. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. QATAR RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 196. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 197. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 198. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 199. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 200. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 201. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 202. FINLAND RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 219. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 220. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 221. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 222. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 223. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 224. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 225. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. EGYPT RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 228. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 229. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 230. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 231. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 232. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 233. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. TURKEY RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 243. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 244. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 245. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 246. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 247. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 248. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 249. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 250. NORWAY RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 252. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 253. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 254. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 255. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 256. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. POLAND RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 276. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 277. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 278. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 279. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 280. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 281. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 283. CHINA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 284. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 285. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 286. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 287. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 288. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 289. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 290. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. INDIA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 292. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 293. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 294. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 295. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 296. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 297. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 298. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 299. JAPAN RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 324. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 325. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 326. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 327. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 328. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 329. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 330. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 331. THAILAND RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY FLUORINE-18, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY GALLIUM-68, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY IODINE-131, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY DELIVERY FORMAT, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY PRODUCTION TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES RADIOPHARMACEUTICALS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 340. MALAYSIA RADIOPHARMACEUTICALS MARKET SIZE, BY RADIOISOTOPE TYPE, 2018-2030 (USD MILLION)
TABLE 341

Companies Mentioned

The companies profiled in this Radiopharmaceuticals market report include:
  • Curium NV
  • Lantheus Holdings, Inc.
  • Cardinal Health, Inc.
  • Eckert & Ziegler AG
  • Jubilant Pharmova Limited
  • GE HealthCare Technologies Inc.
  • Bayer AG
  • Novartis AG
  • Nordion Inc.
  • Ion Beam Applications SA

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.84 Billion
Forecasted Market Value ( USD ) by 2030 $ 8 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Nuclear Medicine Market by Product Type, Mode Of Administration, Usage, Application, End Users - Global Forecast to 2030 - Product Image

Nuclear Medicine Market by Product Type, Mode Of Administration, Usage, Application, End Users - Global Forecast to 2030

  • Report
  • 182 Pages
  • Global
From
Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Nuclear Medicine/Radiopharmaceuticals - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
SPECT & PET Radiopharmaceuticals Market by Modality, Radiopharmaceutical Type, Indication, End User, Distribution Channel - Global Forecast to 2030 - Product Image

SPECT & PET Radiopharmaceuticals Market by Modality, Radiopharmaceutical Type, Indication, End User, Distribution Channel - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Radiopharmaceuticals Market - Products and Applications - Product Image

Radiopharmaceuticals Market - Products and Applications

  • Report
  • 307 Pages
  • Global
From
Radiopharmaceuticals - Global Strategic Business Report - Product Image

Radiopharmaceuticals - Global Strategic Business Report

  • Report
  • 739 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.